Back to Search
ANDREW MILLER, DO
DO
Rheumatology Physician
NPI: 1437354446IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
0102202198(VA)
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 2003
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
The effects of clinical information presentation on physicians' and nurses' decision-making in ICUs.
PMID 18834970·Appl Ergon·2009
3-trial
Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction.
PMID 19342645·J Immunol·2009
7-preclinical
Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus).
PMID 19605896·Vet Pathol·2009
7-preclinical
CLEAR: Central Line Emergency Access Registry. The CLEAR project protocol methods paper.
PMID 19041547·Am J Emerg Med·2009
8-other
Reproducing stone monument photosynthetic-based colonization under laboratory conditions.
PMID 18768211·Sci Total Environ·2008
8-other
Waiting for child developmental and rehabilitation services: an overview of issues and needs.
PMID 18811706·Dev Med Child Neurol·2008
6-review
Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
PMID 18447653·Pharmacotherapy·2008
3-trial
Beyond IP3: roles for higher order inositol phosphates in immune cell signaling.
PMID 18235237·Cell Cycle·2008
6-review
Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B cell selection and activation.
PMID 17417640·Nat Immunol·2007
7-preclinical
Effect of gender and sex hormones on vascular oxidative stress.
PMID 17714091·Clin Exp Pharmacol Physiol·2007
6-review
Live/real-time three-dimensional transthoracic assessment of mitral regurgitation and mitral valve prolapse.
PMID 17765112·Cardiol Clin·2007
6-review
Services for children and youth with chronic health conditions: views of pediatricians in British Columbia.
PMID 17953794·Chronic Dis Can·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 844 KEMPSVILLE RD STE 103B
NORFOLK, VA 23502 - Phone
- (757) 261-0200
Quick Facts
- NPI
- 1437354446
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile